Evidence map›Paper›PMID 31198815›Full record

ArticleOpen forum infectious diseases2019

The Impact of Culturing the Organ Preservation Fluid on Solid Organ Transplantation: A Prospective Multicenter Cohort Study.

I Oriol, N Sabe, J Càmara, D Berbel, M A Ballesteros, R Escudero, F Lopez-Medrano, L Linares, O Len, J T Silva and 28 more

Open access · goldAbstract read
In one paragraph

Article in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. The impact of preservation fluid culture on graft site arteritis: A systematic review and meta-analysis.Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Preservation Fluid Bacteriology in Kidney Transplantation: Comparing Uncontrolled Donation After Circulatory Death With Donation After Brain Death.Transplant international : official journal of the European Society for Organ Transplantation · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Impact of Culture-Positive Preservation Fluid on Early Morbidity and Mortality After Lung Transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
  11. Perioperative antibiotic stewardship in the organ transplant setting.Transplant infectious disease : an official journal of the Transplantation Society · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Observational
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 16 institutions in 1 country.

I OriolInfectious Disease Department, Hospital Universitari de Bellvitge - IDIBELL; L'Hospitalet de Llobregat, Barcelona, Spain.
N SabeInfectious Disease Department, Hospital Universitari de Bellvitge - IDIBELL; L'Hospitalet de Llobregat, Barcelona, Spain.
J CàmaraMicrobiology Department, Hospital Universitari de Bellvitge-Universitat de Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain.
D BerbelMicrobiology Department, Hospital Universitari de Bellvitge-Universitat de Barcelona-IDIBELL, L'Hospitalet de Llobregat, Spain.
M A BallesterosIntensive Care Unit, Marqués de Valdecilla Hospital, University of Cantabria, IDIVAL, Santander, Spain.
R EscuderoInfectious Diseases Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. IRYCIS.
F Lopez-MedranoUnit of Infectious Diseases, Hospital Universitario "12 de Octubre", Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Madrid, Spain.
L LinaresClinical Science Department, Faculty of Medicine, University of Barcelona, Barcelona.
O LenInfectious Diseases Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
J T SilvaUnit of Infectious Diseases, Hospital Universitario "12 de Octubre", Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Madrid, Spain.
E OliverDonor Coordination Unit, Bellvitge University Hospital, Barcelona, Spain.
L SoldevilaInfectious Disease Department, Hospital Universitari de Bellvitge - IDIBELL; L'Hospitalet de Llobregat, Barcelona, Spain.
S Pérez-RecioInfectious Disease Department, Hospital Universitari de Bellvitge - IDIBELL; L'Hospitalet de Llobregat, Barcelona, Spain.
L L GuillemInfectious Disease Department, Hospital Universitari de Bellvitge - IDIBELL; L'Hospitalet de Llobregat, Barcelona, Spain.
D CamprubíInfectious Disease Department, Hospital Universitari de Bellvitge - IDIBELL; L'Hospitalet de Llobregat, Barcelona, Spain.
L LLadóLiver Transplant Unit, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat (Barcelona), Spain.
A ManonellesDepartment of Nephrology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat (Barcelona), Spain.
J González-CostelloDepartment of Cardiology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat (Barcelona), Spain.
M A DomínguezSpanish Network for Research in Infectious Diseases (REIPI).
M C FariñasInfectious Diseases Unit, Marqués de Valdecilla Hospital, University of Cantabria, IDIVAL, Santander, Spain.
N LavidDonor Coordination Unit, Marqués de Valdecilla Hospital, University of Cantabria, IDIVAL, Santander, Spain.
C González-RicoInfectious Diseases Unit, Marqués de Valdecilla Hospital, University of Cantabria, IDIVAL, Santander, Spain.
L Garcia-CuelloInfectious Diseases Unit, Marqués de Valdecilla Hospital, University of Cantabria, IDIVAL, Santander, Spain.
F Arnaiz de Las RevillasInfectious Diseases Unit, Marqués de Valdecilla Hospital, University of Cantabria, IDIVAL, Santander, Spain.
J FortunInfectious Diseases Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. IRYCIS.
J M AguadoUnit of Infectious Diseases, Hospital Universitario "12 de Octubre", Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Madrid, Spain.
C Jimenez-RomeroUnit of Infectious Diseases, Hospital Universitario "12 de Octubre", Instituto de Investigación Sanitaria Hospital "12 de Octubre" (imas12), Madrid, Spain.
M BodroClinical Science Department, Faculty of Medicine, University of Barcelona, Barcelona.
M AlmelaClinical Science Department, Faculty of Medicine, University of Barcelona, Barcelona.
D ParedesClinical Science Department, Faculty of Medicine, University of Barcelona, Barcelona.
A MorenoClinical Science Department, Faculty of Medicine, University of Barcelona, Barcelona.
C Pérez-CameoUniversitat Autònoma de Barcelona, Barcelona, Spain.
A Muñoz-SanzDepartment of Infectious Diseases, Hospital Universitario de Badajoz, Spain.
G Blanco-FernándezLiver Transplant Unit, Hospital Universitario de Badajoz, Spain.
J A Cabo-GonzálezKidney Transplant Unit, Hospital Universitario de Badajoz, Spain.
J L García-LópezDonor Coordination Unit, Hospital universitario de Badajoz, Spain.
E NuñoDonor Coordination Unit, Hospital universitario de Badajoz, Spain.
J CarratalàInfectious Disease Department, Hospital Universitari de Bellvitge - IDIBELL; L'Hospitalet de Llobregat, Barcelona, Spain.
Bellvitge University Hospital · ESCentro de Implantología Cirugía Oral y Maxilofacial · ESInstitut d'Investigació Biomédica de Bellvitge · ESHospital Clínic de Barcelona · ESHospital Universitario 12 De Octubre · ESUniversitat de Barcelona · ESInstituto de Investigación Marqués de Valdecilla · ESMarqués de Valdecilla University Hospital · ESUniversidad de Cantabria · ESCentro de Investigación Biomédica en Red de Enfermedades Respiratorias · ESHospital Universitario Ramón y Cajal · ESInstituto Ramón y Cajal de Investigación Sanitaria · ESRed Espanola de Investigacion en Patologia Infecciosa · ESUniversidad Complutense de Madrid · ESUniversitat Autònoma de Barcelona · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe analyzed the prevalence, etiology, and risk factors of culture-positive preservation fluid and their impact on the management of solid organ transplant recipients.

methodsFrom July 2015 to March 2017, 622 episodes of adult solid organ transplants at 7 university hospitals in Spain were prospectively included in the study.

resultsThe prevalence of culture-positive preservation fluid was 62.5% (389/622). Nevertheless, in only 25.2% (98/389) of the cases were the isolates considered "high risk" for pathogenicity. After applying a multivariate regression analysis, advanced donor age was the main associated factor for having culture-positive preservation fluid for high-risk microorganisms. Preemptive antibiotic therapy was given to 19.8% (77/389) of the cases. The incidence rate of preservation fluid-related infection was 1.3% (5 recipients); none of these patients had received preemptive therapy. Solid organ transplant (SOT) recipients with high-risk culture-positive preservation fluid receiving preemptive antibiotic therapy presented both a lower cumulative incidence of infection and a lower rate of acute rejection and graft loss compared with those who did not have high-risk culture-positive preservation fluid. After adjusting for age, sex, type of transplant, and prior graft rejection, preemptive antibiotic therapy remained a significant protective factor for 90-day infection.

conclusionsThe routine culture of preservation fluid may be considered a tool that provides information about the contamination of the transplanted organ. Preemptive therapy for SOT recipients with high-risk culture-positive preservation fluid may be useful to avoid preservation fluid-related infections and improve the outcomes of infection, graft loss, and graft rejection in transplant patients.

Indexed as

preemptive antibiotic therapypreservation fluidpreservation fluid–related infectionsolid organ transplantation

Identifiers

PMID31198815
PMCPMC6546202
OpenAlexW2940794738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.